Issue: FDA and Drug Regulation
     
 
En Español

The Power of Independent Thinking

←  ISSUES
Issues
›
Regulation
›
FDA and Drug Regulation
›
Commentary

Showing 41 - 50 of 193 Results.

What Can Healthcare Prices Teach About Inflationary Woes?
Raymond J. March | Commentary | June 20, 2022
The CDC’s New Pox Americana
Monkeypox see, monkeypox do.
K. Lloyd Billingsley | Commentary | June 8, 2022
The FDA Could Easily Solve the Baby Formula Shortage by Allowing More Imports from Europe
Raymond J. March, Glenn L. Furton | Commentary | May 18, 2022
The Green Side of White Coat Supremacy
Anthony Fauci and NIH boss Francis Collins got part of $350 million in undisclosed royalties.
K. Lloyd Billingsley | Commentary | May 13, 2022
David Theroux: Gentleman, Scholar, Entrepreneur
Ryan M. Yonk, David Waugh | Commentary | May 5, 2022
There Is No Balm in Gilead
K. Lloyd Billingsley | Commentary | Apr. 21, 2022
The Public-Health Hazards Posed by Public-Health Paternalists
Donald J. Boudreaux | Commentary | Mar. 21, 2022
The William Barr Code
The former attorney general’s memoir is one deep state revelation after another.
K. Lloyd Billingsley | Commentary | Mar. 18, 2022
Should I Vaccinate My Child Against Covid?
Martin Kulldorff | Commentary | Mar. 11, 2022
Vaccine Cronyism
Raymond J. March | Commentary | Feb. 22, 2022






  • Catalyst
  • Beyond Homeless
  • MyGovCost.org
  • FDAReview.org
  • OnPower.org
  • elindependent.org
© 2024 INDEPENDENT INSTITUTE, 100 SWAN WAY, OAKLAND CA 94621‑1428 | (510) 632‑1366 | (510) 568‑6040 FAX | SEND EMAIL